Prescribing of drugs in pediatric outpatients in Germany;"Off-label" verschreibung von arzneimitteln in der ambulanten versorgung von kindern und jugendlichen

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 48, 2002, Pages 2551-2557

  Bucheler R ^a,c   Meisner, C ^a   Kalchthaler, B ^c   Mohr, H ^c   Schroder H ^d   Morike K ^a   Schwoerer, P ^c   Schwab, M ^b   Gleiter, Christoph H ^a,e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Dr M F B Inst Klin Pharmakol   (Germany)

^c Med D der K Baden Wurttemberg   (Germany)

^d Wissenschaftliches Institut der AOK WIdO   (Germany)

^e KKS UKT gGmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARDIOVASCULAR AGENT; DERMATOLOGICAL AGENT; TOPICAL AGENT;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; EAR DISEASE; EYE DISEASE; GERMANY; HEALTH INSURANCE; HUMAN; INFANT; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; NEWBORN; OUTPATIENT DEPARTMENT; PEDIATRICS; PRESCRIPTION; SKIN DISEASE; TOPICAL TREATMENT; UROGENITAL TRACT DISEASE;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG LABELING; FAMILY PRACTICE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; INTERNAL MEDICINE; OUTPATIENTS; PEDIATRICS; PRESCRIPTIONS, DRUG;

EID: 18744415023     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35819     Document Type: Article

References (38)

1. American Academy of Child and Adolescent Psychiatry (AACAP) - Medical Speciality Society. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998; 37: 63S-83S(Suppl 10)
2. Baving L, Schmidt MH. Evaluierte behandlungsansätze in der kinder- und jugendpsychiatrie. Z Kinder-Jugendpsychiatr 2001; 29: 206-220
3. BPI Service GmbH. Fachinfo: Fachinformationsverzeichnis Deutschland. Berlin 1999, Satz-Rechen-Zentrum: Ausgabe CD, 1999/1
4. Buchhorn R, Ross RD, Hulpke-Wette M et al. Effectiveness of low dose captopril versus propranolol therapy in infants with severe congestive failure due to left-to-right shunts. Int J Cardiol 2000; 76: 227-233
5. Bücheler R, Schwab M, Mörike K et al. Off label prescribing to children in primary care in Germany: Retrospective cohort study. BMJ 2002; 324: 1311-1312
6. Chalumeau M, Tréluyer JM, Salanave B et al. Off label and unlicensed drug use among French office based pediatricians. Arch Dis Child 2000; 83: 502-505
7. Conroy S, Choonara I, Impicciatore P et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79-82
8. Dahl M, Wiesemann C. Forschung an minderjährigen im internationalen vergleich: Bilanz und zukunftsperspektiven. Ethik Med 2001; 13: 87-110
9. Di Carlo G, Borrelli F, Izzo AA, Ernst E. St John's wort: Prozac from the plant kingdom. Trends Pharmacol Sci 2001: 22: 292-297
10. Fegert JM, Rotharmel S. Psychisch kranke kinder und jugendliche als waisenkinder des wirtschaftlichkeitsgebots? Praxis Kinderpsychol Kinderpsychiatr 2000; 49: 127-132
11. Food and Drug Administration Modernization Act of 1997. Pub Law 105-115; USC 355a; 111 Stat 2296, 1997 Nov 21
12. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134-138
13. Hübner WD, Kirste T. Experience with St John's Wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res 2001; 15: 367-370
14. Knöppel C, Klinger O, Soergel M, Seyberth HW, Leonhardt A. Anwendung von medikamenten außerhalb der zulassung oder ohne zulassung bei kindern. Monatsschr Kinderheilkd 2000; 148: 904-908
15. Laer S, Meibohm B et al. Termination of automatic atrial tachycardia in an infant by adequate sotalol dosing. Eur J Clin Pharmacol 2001; 57: 181-182
16. Laer S, Wauer I, Behn F et al. M. Pharmacokinetics of sotalol in different age groups of children with tachycardia. J Pediatr Pharmacol Ther 2001; 6: 50-69
17. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care 2000; 16: 394-397
18. Lifshitz M, Gavfilov V, Gorodischer R. Use of unlicensed and off-label drugs in hospital children. Harefuah 1999; 137: 532-534, 591
19. Madlon-Kay DJ, Mosch FT. Liquid medication dosing errors. J Fam Pract 2000; 49: 741-744
20. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescription of drugs in general practice. Arch Dis Child 2000; 83: 498-501
21. MediMedia Medizinische Medien Informations GmbH. Gelbe Liste Pharmindex. Neu-Isenburg, CD 1/1999. 1999
22. Menniti-Ippolito F, Raschetti R, Da Cas R, Giaquinto C, Cantarutti L for the Italian Paediatric Pharmacosurveillance Multicenter Group. Active monitoring of adverse drug reactions in children. Lancet 2000; 355: 1613-1614
23. Mintegui RS, Benito FJ, Vasquez RM, Fernandez LA, Gortazar AP, Grau BG. Emergency department visits for poisoning. An Esp Pediatr 2002; 56: 23-29
24. Rote Liste Service GmbH. Rote Liste. Aulendorf, Editio Cantor Verlag, 1999
25. Schwab M, Gleiter CH, Brochhausen C, Seyberth HW. Arzneimittelsicherheit in der pädiatrie verhessern. Dt Ärztebl 2000; 97: C1404-C1405
26. Schirm E, Tobi H, de Jong-van den de Berg LTW. Unlicensed and off label drug use by children in the community: Cross sectional study. BMJ 2002; 324: 1312-1313
27. Seyberth HW, Brochhausen C, Kurz R. Probleme der pädiatrischen pharmakologie und deren internationale lösungsansätze. Monatsschr Kinderheilkd 2002; 150: 218-225
28. Statistisches Landesamt Baden-Württemberg 2002. Bevölkerungsentwicklung in Baden-Württemberg seit 1950 nach Altersgruppen und Geschlecht. Ergebnisse der Bevölkerungsfortschreibung zum Jahresende, http://www.statistik.ba-den-wuerttemberg.de/BevoelkGebiet/ LandesdatenlMZhevAlter.asp. 1999
29. Steffensen GK, Pachai A, Pedersen SE. Peroral medicinsk behandling af born-er der problemer? Ugeskr Laeger 1998; 160: 2249-2252
30. The European Agency for the Evaluation of Medicinal Products (EMEA). Topic E11 Step 4. Note for Guidance on Clinical Investigation of Medicinal Products in the Paediatric Population. (CPMP/ICH/2711/99 - adopted London, July 2000), http://www.emea.eu.int/htms/human/ich/efficacy/ichfin.htm.
31. Thorpe L, Withney DK, Kutcher SP, Kennedy SH and the CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatr 2001; 46: 63S-76S
32. 'tJong GW, Vulto AG et al. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108: 1089-1093
33. 'tJong GW, Eland IA, Sturkenboom MCJM et al. Unlicensed and off label prescription of drugs to children. BMJ 2002; 324: 1313-1314
34. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in pediatric wards: Prospective study. BMJ 1998; 316: 343-345
35. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to "unlicensed" and "off-label" drugs on paediatric wards. Acta Paediatr 1999; 88: 965-968
36. Volz HP, Möller HJ, van Schayck R. SSRI in der kinder- und jugendpsychiatrie. 1. Auflage, wissenschaftliche verlagsgesellschaft, Stuttgart, In: Gleiter CH, Volz HP, Möller HJ (Hrsg.). Serotonin-Wiederaufnahmehemmer. Pharmakologie und Therapeutischer Einsatz. 1999: 137-138
37. Wells T, Rippley R, Hogg R. The pharmacokinetics of enalapril in children and infants with hypertension. J Clin Pharmacol 2001; 41: 1064-1074
38. WIdO, Wissenschaftliches Institut der AOK. Fricke U (Hrsg.). Aktuelle ATC-Klassifikation mit Deutscher Erweiterung in Ausdruckbarer Form, Stand Mai 2000, http://www.WIdO.de/Arzneimittel/ATC/index.html.